December 15, 2025: Ozempic Blindness MDL Is Created for Patients Who Suffered Eye Stroke After Taking GLP-1s Patients diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION) after taking Ozempic, other GLP-1s, can file a lawsuit in the new MDL created for these cases
The addition of semaglutide to standard of care was associated with an important gain in life-years free of new and recurrent CVD events and a decrease in 10-year CVD risk, Jan Westerink , MD, PhD , internist in the department of vascular medicine at the University Medical Centre Utrecht in the Netherlands, and colleagues wrote
The medication is used off-label for weight management
Nausea, especially during dose escalation, affects a significant percentage of users
Michigan to limit Medicaid coverage for weight loss drugs to people with diabetes, morbid obesity Michigan's new bipartisan state budget will limit Medicaid coverage of a group of weight loss drugs whose use has exploded in popularity in recent years